Osaka, Japan

Miho Maeda

This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Pharmaceuticals Company Limited. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miho Maeda. Retrieved from https://idiyas.com/inventor/miho-maeda-kme6onfl

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Miho Maeda: Innovator in Controlled Release Formulations

Introduction

Miho Maeda is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. Her innovative work has the potential to enhance the efficacy of various active ingredients in medical applications.

Latest Patents

Miho Maeda holds a patent for a controlled release formulation. This formulation comprises a compound selected from organic acidic compounds and acid anhydrides or esters capable of generating one of the organic acidic compounds through hydrolysis. It also includes an active ingredient and collagen as a carrier, allowing for a predetermined release profile of the active ingredient. Additionally, a process for producing this formulation is provided.

Career Highlights

Miho Maeda is associated with Sumitomo Pharmaceuticals Company Limited, where she has been instrumental in advancing pharmaceutical innovations. Her work focuses on improving drug delivery systems, which can significantly impact patient treatment outcomes.

Collaborations

Some of her notable coworkers include Keiji Fujioka and Shigeji Sato, who collaborate with her on various projects within the company.

Conclusion

Miho Maeda's contributions to controlled release formulations exemplify her dedication to pharmaceutical innovation. Her work continues to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…